Comment Re:Explanation? (Score 1) 266
It doesn't affect the patent. It affects the prescribability.
First, there is a break, when X cannot be prescribed (not made by the company, patent prevents generics), So the only option is X+1, which then becomes the entrenched standard.
Also, some jurisdictions don't allow generics for X to be prescribed. X is prescribed, and the generic can be substituted. So, by stopping the sale, they prevent the generic.
The latter can be fixed by changing the law... the former is a far more pernicious issue.